# LIALDA
> **NDA022000** · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2007-01-16
## Drug
- **FDA Application Number:** NDA022000
- **Application type:** New Drug Application
- **Brand name:** LIALDA
- **Generic name:** MESALAMINE
- **Active ingredients:** MESALAMINE
- **Dosage form:** TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TAKEDA PHARMS USA
- **Manufacturer:** Takeda Pharmaceuticals America, Inc.
- **First approval:** 2007-01-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022000)
---
*MORVS · CC0 1.0*